Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Shanghai Pharma Biotherapeutics USA Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT05580588
- Locations
- 🇺🇸
Mayo Clinic Hospital, Phoenix, Arizona, United States
🇺🇸City of Hope, Duarte, California, United States
🇺🇸Mayo Clinic Florida, Jacksonville, Florida, United States
Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis
- First Posted Date
- 2021-08-25
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Shanghai Pharma Biotherapeutics USA Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT05019742
- Locations
- 🇺🇸
Clinical Research Associates, LLC, Huntsville, Alabama, United States
🇺🇸Southern California Research Institute Medical Group, Inc., Los Angeles, California, United States
🇺🇸Facey Medical Group at Facey Medical Foundation, Mission Hills, California, United States
News
No news found